Healthcare provider profile · identity verified

Isaac Spence, D.O.

Family Practice · BLACKSBURG, VA · NPI 1760772552

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	523	136
Levothyroxine Sodium	Levothyroxine Sodium	399	92
Losartan Potassium	Losartan Potassium	362	92
Amlodipine Besylate	Amlodipine Besylate	329	87
Atorvastatin Calcium	Atorvastatin Calcium	305	85
Lisinopril	Lisinopril	263	74
Furosemide	Furosemide	245	61
Duloxetine Hcl	Duloxetine Hcl	243	59
Gabapentin	Gabapentin	233	51
Omeprazole	Omeprazole	194	48
Eliquis	Apixaban	182	35
Metoprolol Succinate	Metoprolol Succinate	172	50
Metformin Hcl	Metformin Hcl	171	47
Tamsulosin Hcl	Tamsulosin Hcl	171	48
Trazodone Hcl	Trazodone Hcl	164	42
Escitalopram Oxalate	Escitalopram Oxalate	142	32
Montelukast Sodium	Montelukast Sodium	142	35
Carvedilol	Carvedilol	139	35
Hydrochlorothiazide	Hydrochlorothiazide	134	36
Pravastatin Sodium	Pravastatin Sodium	132	35
Famotidine	Famotidine	124	41
Sertraline Hcl	Sertraline Hcl	122	29
Metformin Hcl Er	Metformin Hcl	119	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	114	27
Pantoprazole Sodium	Pantoprazole Sodium	111	32
Fluticasone Propionate	Fluticasone Propionate	110	34
Meloxicam	Meloxicam	106	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	16
Potassium Chloride	Potassium Chloride	94	17
Lorazepam	Lorazepam	92	16
Simvastatin	Simvastatin	92	23
Glipizide Er	Glipizide	85	25
Albuterol Sulfate Hfa	Albuterol Sulfate	84	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	79	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	21
Mirtazapine	Mirtazapine	74	21
Jardiance	Empagliflozin	72	19
Spironolactone	Spironolactone	68	17
Ozempic	Semaglutide	67	15
Prednisone	Prednisone	66	41
Tramadol Hcl	Tramadol Hcl	66	16
Bupropion Xl	Bupropion Hcl	65	19
Allopurinol	Allopurinol	64	18
Metoprolol Tartrate	Metoprolol Tartrate	63	17
Alendronate Sodium	Alendronate Sodium	62	21
Doxazosin Mesylate	Doxazosin Mesylate	60	15
Mounjaro	Tirzepatide	60	13
Buspirone Hcl	Buspirone Hcl	59	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	16
Chlorthalidone	Chlorthalidone	58	19
Synthroid	Levothyroxine Sodium	58	15
Finasteride	Finasteride	56	15
Olmesartan Medoxomil	Olmesartan Medoxomil	53	13
Calcitriol	Calcitriol	52	15
Alprazolam	Alprazolam	51	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	51	16
Celecoxib	Celecoxib	49	17
Trulicity	Dulaglutide	49	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	46	11
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	13
Glimepiride	Glimepiride	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	41	12
Warfarin Sodium	Warfarin Sodium	38	suppressed
Clonazepam	Clonazepam	37	11
Azithromycin	Azithromycin	33	12
Symbicort	Budesonide/Formoterol Fumarate	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Atenolol	Atenolol	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Naproxen	Naproxen	30	suppressed
Ramipril	Ramipril	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	18
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Azelastine Hcl	Azelastine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Ondansetron Odt	Ondansetron	24	15
Methotrexate	Methotrexate Sodium	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	13
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Baclofen	Baclofen	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Diazepam	Diazepam	19	11
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Colchicine	Colchicine	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Lubiprostone	Lubiprostone	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Tadalafil	Tadalafil	17	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Dulera	Mometasone/Formoterol	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Lamotrigine Er	Lamotrigine	15	suppressed
Methimazole	Methimazole	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Temazepam	Temazepam	15	suppressed
Estradiol	Estradiol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Flunisolide	Flunisolide	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Primidone	Primidone	13	suppressed
Topiramate	Topiramate	13	suppressed
Cephalexin	Cephalexin	12	11
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Clonidine	Clonidine	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Trulance	Plecanatide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error